Patients with a history of pancreatitis, severe gastrointestinal disease, gallbladder problems, certain endocrine cancers, or complex medication regimens should be evaluated carefully before considering incretin-based therapies
Most people notice reduced appetite within 7-14 days of the first injection, though effects strengthen with each dose increase
If your 10 units from a 5 mg/mL vial (0.5 mg) produces effects consistent with a much higher or much lower dose, it could indicate a concentration mismatch
When traveling, transport injectable semaglutide in an insulated medication cooler with ice packs, ensuring the pen does not come into direct contact with ice (which could cause freezing)
Medication concentrations, syringe types, and prescribed doses can vary